Patient and Family Services During Cancer Care
Patient and Family Services During Cancer Care
Patient and Family Services During Cancer Care
Radiation Oncology
This is an open-label, multicenter, Phase 1 dose-escalation study to establish the safety and tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) and to identify a maximum tolerated dose (MTD) and/or maximum feasible dose (MFD).
Our Community Outreach and Engagement Impact
Cardio-Oncology Program
Gynecologic Oncology Program
COE Community Advisory Board